HISTIOCYTIC NEOPLASM
Clinical trials for HISTIOCYTIC NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new HISTIOCYTIC NEOPLASM trials appear
Sign up with your email to follow new studies for HISTIOCYTIC NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets Hard-to-Treat cancers: early trial recruits 554 patients
Disease control Recruiting nowThis study tests an experimental oral drug called S241656 (BDTX-4933) in people with advanced solid tumors that have certain genetic changes (KRAS, BRAF, or other RAS/MAPK mutations). The trial has two parts: first, finding a safe dose, then testing how well it works alone or wit…
Matched conditions: HISTIOCYTIC NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Last-Resort drug access opens for rare tumor patients
Disease control AVAILABLEThis program provides mirdametinib to individual patients with serious, life-threatening conditions like neurofibromatosis type 1 tumors or other MAP-K pathway diseases who have no other treatment options and cannot join a clinical trial. Each case requires approval from the comp…
Matched conditions: HISTIOCYTIC NEOPLASM
Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New registry aims to unlock mysteries of rare histiocyte disorders
Knowledge-focused Recruiting nowThis study creates a registry for people with Erdheim-Chester disease and related histiocytoses. Researchers will collect medical information and patient experiences over time to better understand these rare conditions. Up to 500 participants will be enrolled, and some may be ask…
Matched conditions: HISTIOCYTIC NEOPLASM
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC